Hematology in Israel: hematology center at Ichilov clinic for international patients

One of the largest specialized centers is the Tel Aviv Sourasky medical center (Ichilov), which operates a dedicated hematology department well known among international patients. The Ichilov hematology hospital receives patients from various countries and organizes treatment in accordance with international standards.

Treatment of blood diseases in Israel includes both oncohematological and non-oncological conditions. Malignant diseases include acute and chronic leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, and myeloproliferative disorders. Benign conditions include various forms of anemia, aplastic anemia, coagulation disorders, thrombocytopenia, and hereditary hematological syndromes.

To establish an accurate diagnosis, comprehensive laboratory tests, immunological and molecular genetic studies, cytogenetics, and advanced imaging methods are used. This integrated approach makes it possible to determine the biological characteristics of the disease and select a personalized treatment plan. For this reason, blood treatment in Israel is often considered by patients as an opportunity to receive more precise diagnostics and an individualized therapy strategy.

Modern hematology in Israel is based on the principles of personalized medicine. Treatment is selected according to the genetic characteristics of the tumor, the patient’s age, comorbidities, and response to previous therapy.

Current clinical practice includes modern chemotherapy protocols, targeted therapies, immunotherapy, cellular technologies, as well as supportive and symptomatic care. For a number of conditions, bone marrow transplantation in Israel becomes a key treatment method, allowing long-term remission or complete recovery to be achieved.

Bone marrow transplantation in Israel is performed for acute leukemias, aggressive lymphomas, multiple myeloma, aplastic anemia, and certain hereditary blood disorders. Depending on the clinical situation, autologous transplantation (the patient’s own stem cells) or allogeneic transplantation (stem cells from a related or unrelated donor) may be used. In some cases, haploidentical transplantation with partial compatibility is possible.

The transplantation process includes several sequential stages:

1. Preliminary examination and donor selection (for allogeneic transplantation).
2. Conditioning therapy — intensive treatment aimed at destroying pathological cells and preparing the body for transplantation.
3. Infusion of stem cells and the subsequent engraftment period.
4. Long-term follow-up with immune system monitoring and prevention of complications, including graft-versus-host disease.

Hospitalization usually lasts several weeks, after which the patient continues outpatient follow-up. For international patients, it is important to consider in advance the length of stay and the need for accompaniment.

In severe blood disorders, the time factor plays a decisive role. That is why many patients pay attention to the format of international departments, which allows them to begin examination and therapy in the hematology department without waiting.

Organization of treatment in the hematology department without queues usually begins with the remote submission of medical documents. After reviewing them, specialists prepare a preliminary diagnostic and treatment plan, assess indications for transplantation, and determine the estimated cost. This approach helps minimize repeated examinations and start treatment more quickly upon arrival.

The hematology department based at the Tel Aviv Sourasky Medical Center combines diagnostic laboratories, inpatient departments, a bone marrow transplantation unit, and an intensive care service. Patients have access to multidisciplinary consultations and modern international treatment protocols.

Treatment of blood disorders in Israel includes a full cycle of medical care: from in-depth diagnostics to high-tech therapy and rehabilitation follow-up. A special place is occupied by bone marrow transplantation in Israel, which remains one of the most effective treatment methods for a number of severe hematological diseases.

When choosing a treatment program, it is important to consider the stage of the disease, the patient’s general condition, donor availability, and the recommendations of specialized physicians. Clinic specialists can assist with this and can be contacted via the following link. A comprehensive and individualized approach, as well as clear organization of the process, help increase the chances of a successful outcome and safe completion of all stages of therapy.